SCHEMBL7094187

SCHEMBL7094187

CCN(CC)CCN(C(N)=O)c1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 14/20 0.53
KDR P35968 4/20 0.52
CDK2 P24941 2/20 0.49
CDK1 P06493 1/20 0.49
NPC1 O15118 1/20 0.40
IKBKB O14920 1/20 0.40
MAP4K4 O95819 1/20 0.40
PIM1 P11309 1/20 0.40
RPS6KB1 P23443 1/20 0.40
MARK3 P27448 1/20 0.40
AKT1 P31749 1/20 0.40
AKT2 P31751 1/20 0.40
FLT3 P36888 1/20 0.40
RPS6KA3 P51812 1/20 0.40
PLK1 P53350 1/20 0.40
PRKAA1 Q13131 1/20 0.40
STK3 Q13188 1/20 0.40
MELK Q14680 1/20 0.40
MARK2 Q7KZI7 1/20 0.40
AURKB Q96GD4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7832418 0.94 CHEK1 (0.51) CHEK1KDRCDK2CDK1NPC1
SCHEMBL7184665 0.94 CHEK1 (0.51) CHEK1KDRCDK2CDK1NPC1
SCHEMBL7840336 0.88 CHEK1 (0.57) CHEK1KDRCDK2CDK1NPC1
SCHEMBL7848969 0.87 CHEK1 (0.49) CHEK1KDRCDK2CDK1NPC1
SCHEMBL7832382 0.86 CHEK1 (0.52) CHEK1KDRCDK2CDK1NPC1
SCHEMBL7094279 0.83 KDR (0.58) CHEK1KDRCDK2CDK1
SCHEMBL7840666 0.83 CHEK1 (0.51) CHEK1KDRCDK2CDK1
SCHEMBL7838497 0.81 CHEK1 (0.49) CHEK1KDRCDK2CDK1NPC1
SCHEMBL7832987 0.81 CHEK1 (0.54) CHEK1KDRCDK2CDK1MAP4K4
SCHEMBL7697858 0.81 CDK1 (0.60) CHEK1KDRCDK2CDK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed